Skip to content

A randomized controlled study on the treatment of primary dysmenorrhea with heat burning blood stasis by Guizhi Fuling Wan

A randomized controlled study on the treatment of primary dysmenorrhea with heat burning blood stasis by Guizhi Fuling Wan

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034118
Enrollment
Unknown
Registered
2020-06-24
Start date
2020-09-12
Completion date
Unknown
Last updated
2020-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhea

Interventions

Sponsors

Yichang Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
16 Years to 30 Years

Inclusion criteria

Inclusion criteria: Those who meet the following 7 items can be included in the study. If there is any inconformity, the patient cannot enter the study 1. Patients aged 16-30 years; 2. To diagnose patients with primary dysmenorrhea according to the consensus guideline of primary dysmenorrhea; 3. No parturient; 4. Self described pain duration: from 6 months to 15 years; 5. Patients with an average pain intensity of 40 or more (VAS by 100 mm visual analogue scale) and at least three consecutive menstrual cycles; 6. Patients with syndrome of heat burning and blood stasis; 7. The informed consent shall be signed by the patient himself or by his immediate relatives.

Exclusion criteria

Exclusion criteria: Patients cannot enter the study if any of the following are met: 1. Patients who can not complete the treatment plan of this study within half a year; 2. Patients with secondary dysmenorrhea (such as endometriosis or adenomyosis); 3. Patients with irregular menstrual cycle (beyond the typical range of 21-35 days); 4. Women with pregnancy plan in the past half year; 5. Patients with mental disorders and mental disorders who can not cooperate with the questionnaire survey; 6. Patients with serious cardiovascular disease, liver and kidney function damage, psychological disease or life-threatening situation; 7. Patients who are using analgesics; 8. Patients who have participated in or are participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
visual analog scale (VAS) scores;

Secondary

MeasureTime frame
the TCM syndrome score;Cox Menstrual Symptom Scale (CMSS);Self-rating Depression Scale;Self-rating Anxiety Scale;

Countries

China

Contacts

Public ContactChenjie Li

Three Gorges University

179073543@qq.com+86 13085157861

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 20, 2026